Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

AIM/HCM stock hub

AIM/HCM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/HCMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.7B

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/HCM

In the news

Latest news · AIM/HCM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E24.3

P25 12.9P50 16.9P75 23.5

Trailing P/E5

P25 15.9P50 22.9P75 35.8

ROE45.3

P25 -54.2P50 2.1P75 13.7

ROIC-1,741.7

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/HCM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

200

Groups with data

Currency

USD

Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	UK
Employees	1,796
Employees Change	-15%
Employees Change Percent	-0.83
Enterprise value	GBX 742M
Exchange	London Stock Exchange AIM
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KYG4672N1198
Last refreshed	2026-05-10
Market cap	GBX 1.7B
Price	GBX 195
Price currency	GBX
Rev Per Employee	226,917.83x
Sector	Healthcare
Sic	2834
Symbol	aim/HCM
Website	https://www.hutch-med.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	20.25%
EV Earnings	2.19x
EV/FCF	-12.67x
EV/Sales	1.82x
FCF yield	-3.49%
Forward P/E	24.29x
P/B ratio	1.8x
P/E ratio	5.05x
P/S ratio	4.11x
PE Ratio3 Y	18.71x
PE Ratio5 Y	37.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.14%
EBITDA Margin	-4.71%
Gross margin	11.64%
Gross Profit	GBX 47.5M
Gross Profit Growth	18.8%
Gross Profit Growth5 Y	-17.78%
Net Income	GBX 339.5M
Net Income Growth	1,111.03%
Net Income Growth Q	-83.61%
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	95.05%
Profit Margin	83.3%
Profit Per Employee	GBX 189,022
Profitable Years	3
ROA	-1.62
Roa5y	-8.71
ROCE	-2.72
ROE	45.25
Roe5y	0.1
ROIC	-1,741.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.2%
Cagr15y	11%
Cagr1y	-13.53%
Cagr3y	-9.43%
Cagr5y	-12.77%
EPS Growth	1,200
EPS Growth Q	-98.06
EPS Growth Quarters	2
EPS Growth Years	1
FCF Growth Q	-89.68%
OCF Growth Q	-79.58%
Revenue Growth	-12.96x
Revenue Growth Q	-16.54x
Revenue Growth Years	0x
Revenue Growth3 Y	-3.52x
Revenue Growth5 Y	-6.25x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.36
Assets	GBX 1.3B
Cash	GBX 1B
Current Assets	GBX 1.1B
Current Liabilities	GBX 231.6M
Debt	GBX 72.7M
Debt Equity	GBX 0.08
Debt FCF	GBX -1.24
Equity	GBX 929.7M
Interest Coverage	-13.67
Liabilities	GBX 372.9M
Long Term Assets	GBX 152.9M
Long Term Liabilities	GBX 141.2M
Net Cash	GBX 944.4M
Net Cash By Market Cap	GBX 56.33
Net Cash Growth	69.89%
Net Debt Equity	GBX -1.02
Tangible Book Value	GBX 917.5M
Tangible Book Value Per Share	GBX 1.07
WACC	6.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.96
Inventory Turnover	10.59
Net Working Capital	GBX -66.5M
Quick ratio	4.81
Working Capital	GBX 929.9M
Working Capital Turnover	GBX 0.42

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	12.72%
1Y total return	-13.53%
200-day SMA	222.3
3Y total return	-25.71%
50-day SMA	209.5
50-day SMA vs 200-day SMA	50under200
5Y total return	-49.48%
All Time High	656
All Time High Change	-70.27%
All Time High Date	2021-06-30
All Time Low	3.5
All Time Low Change	5,471.43%
All Time Low Date	2008-12-17
ATR	10.31
Beta	0.38
Beta1y	0.65
Beta2y	0.32
Ch YTD	-6.25
High	202
High52	292
High52 Date	2025-07-29
High52ch	-33.22%
Low	191
Low52	191
Low52 Date	2025-12-23
Low52ch	2.11%
Ma50ch	-6.92%
Price vs 200-day SMA	-12.29%
RSI	37.46
RSI Monthly	42.2
RSI Weekly	41.28
Sharpe ratio	-0.19x
Sortino ratio	-0.16
Total Return	-0.01%
Tr YTD	-6.25
Tr15y	378.53%
Tr1m	-12.16%
Tr3m	-8.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -29.1M
Operating margin	-7.14

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	508,428,282%
Net Borrowing	4,590,330.6
Shares Insiders	0.98%
Shares Institutions	24.13%
Shares Out	859,744,319
Shares Qo Q	0.07%
Shares Yo Y	0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -69.9M
Average Volume	43,690.25x
Bv Per Share	1.07
CAPEX	GBX -10.5M
Ch10y	12.72
Ch15y	378.5
Ch1m	-12.16
Ch1y	-13.53
Ch3m	-8.88
Ch3y	-25.71
Ch5y	-49.48
Ch6m	-17.37
Change	1.04%
Change From Open	1.83
Close	193
Days Gap	-0.78
Depreciation Amortization	9,761,604.3
Dollar Volume	7,458,750
Earnings Date	2026-03-05
EBIT	GBX -29.1M
EBITDA	GBX -19.2M
EPS	GBX 0.39
F Score	3
FCF	GBX -58.6M
FCF EV Yield	-7.89x
FCF Per Share	GBX -0.07
Financing CF	5,822,148
Fiscal Year End	December
Founded	2,000
Goodwill	2,282,695.6
Graham Number	309.956
Graham Upside	58.95
Income Tax	GBX 47.3M
Investing CF	-21,851,630
Is Primary Listing	1
Last Earnings Date	2026-03-05
Last Report Date	2025-12-31
Last Split Date	2019-05-30
Last Split Type	Forward
Ma150	215.9
Ma150ch	-9.7%
Ma20	207.2
Ma20ch	-5.88%
Net CF	-61,392,604
Open	191.5
Position In Range	36.36
Ppne	71,627,642.1
Price Date	2026-05-08
Ptbv Ratio	1.83
Relative Volume	0.91x
Revenue	407,544,416x
SBC By Revenue	2.79x
Share Based Comp	11,361,956
Tax By Revenue	11.6x
Tax Rate	12.2%
Tr6m	-17.37%
Volume	38,250
Z Score	3.9

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/HCM pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/HCM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/HCM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+24.1%

Share of float held by funds and institutions

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

AIM/HCM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.5

Neutral momentum band

Price vs 200-day MA

-12.3%

50/200-day relationship not available

Beta (5Y)

0.38

Less volatile than the market

Sharpe ratio

-0.19

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/HCM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/HCM stock rating?

aim/HCM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/HCM analysis?

The full report lives at /stocks/aim/HCM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/HCM?

The latest report frames aim/HCM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/HCM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.